Cargando…
Tuberculosis in times of COVID-19
The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is...
Autores principales: | Zimmer, Alexandra Jaye, Klinton, Joel Shyam, Oga-Omenka, Charity, Heitkamp, Petra, Nawina Nyirenda, Carol, Furin, Jennifer, Pai, Madhukar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453591/ https://www.ncbi.nlm.nih.gov/pubmed/34535539 http://dx.doi.org/10.1136/jech-2021-217529 |
Ejemplares similares
-
TB and COVID – Public and private health sectors adapt to a new reality
por: Klinton, Joel Shyam, et al.
Publicado: (2020) -
Commentary: Lessons from the COVID-19 global health response to inform TB case finding
por: Oga-Omenka, Charity, et al.
Publicado: (2021) -
Pharmacy engagement in TB prevention and care: not if, but how?
por: Miller, Rosalind, et al.
Publicado: (2023) -
Partnering with the private laboratories to strengthen TB diagnostics in Nigeria
por: Ali, Taofeekat, et al.
Publicado: (2023) -
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
por: Dowdy, David W., et al.
Publicado: (2011)